Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations

Modern Rheumatology

Volumn 18, Issue 1, 2008, Pages 57-59

  Sugiura, Tomoko ^a   Kawaguchi, Yasushi ^a   Fujikawa, Satoru ^a   Hirano, Yukiko ^a   Igarashi, Toru ^b   Kawamoto, Manabu ^a   Takagi, Kae ^a   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Familial Mediterranean fever; MEFV; Mutation; Periodic fever; Pyrin

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; GENE PRODUCT; INTERLEUKIN 1BETA; PROTEIN MEFV; PYRIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BACKACHE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMAN; JAPANESE; JUVENILE RHEUMATOID ARTHRITIS; MALE; MUTATION RATE; PRIORITY JOURNAL; SOUTHERN EUROPE; THORAX PAIN;

ADOLESCENT; COLCHICINE; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENOTYPE; GOUT SUPPRESSANTS; HUMANS; JAPAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 39149115353     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0003-2     Document Type: Article

References (18)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227-53.
2. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
3. Tomiyama N, Oshiro S, Higashiuesato Y, et al. End-stage renal disease associated with familial Mediterranean fever. Intern Med. 2002;41:221-4.
4. Yoshida K, Kanaoka S, Kajimura M, et al. A Japanese case of familial Mediterranean fever with family history demonstrating a mutation in MEFV. Intern Med. 2003;42:761-4.
5. Kotone-Miyahara Y, Takaori-Kondo A, Fukunaga K, et al. E148Q/M694I mutation in 3 Japanese patients with familial Mediterranean fever. Int J Hematol 2004;79:235-7.
6. Nakamura A, Yazaki M, Tokuda T, Hattori T, Ikeda S. A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. Intern Med. 2005;44:261-5.
7. Kim S, Ikusaka M, Mikasa G, et al. Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation. Intern Med. 2007;46:221-5.
8. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879-85.
9. Booth DR, Gillmore JD, Lachmann HJ, et al. The genetic basis of autosomal dominant familial Mediterranean fever. QJM. 2000;93:217-21.
10. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473-83.
11. Tchernitchko DO, Gérard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis. 2006;65:1154-7.
12. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: Prevalence, penetrance and genetic drift. Eur J Hum Genet. 2001;9:634-7.
13. Cazeneuve C, Sarkisian T, Pêcheux C, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet. 1999;65:88-97.
14. Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591-604.
15. Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA. 2006;103:9982-7.
16. Majeed HA, EL-Shanti H, Al-Khateeb MS, Rabaiha ZA. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum. 2002;31:371-6.
17. Pras E, Livneh A, Balow JE, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998;75:216-9.
18. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986;314:1001-5.